This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pluristem Therapeutic
PSTI : NASDAQ : Health Care
$2.65 0.04 | 1.44%
Today's Range: 2.61 - 2.65
Avg. Daily Volume: 115,100
08/22/14 - 9:34 AM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
PSTI PLURISTEM THERAPEUTICS INC 2.62 177.93 n/m 0.38 -44.53
BTX BIOTIME INC 3.00 221.07 n/m 4.89 26.11
NBS NEOSTEM INC 5.99 211.16 n/m 16.33 16.07
AGEN AGENUS INC 3.30 206.84 n/m 4.92 27.01
BSTC BIOSPECIFICS TECHNOLOGIES CP 29.45 190.75 48.28 12.63 -4.37
NAVB NAVIDEA BIOPHARMACEUTICALS 1.26 189.80 n/m 2.76 1267.32
CBMG CELLULAR BIOMEDICINE GROUP 22.68 171.90 n/m 5.77 2857.94
CYTK CYTOKINETICS INC 4.50 164.74 n/m 44.59 678.36
SRNE SORRENTO THERAPEUTICS INC 5.42 154.65 n/m 1.30 114.14
STML STEMLINE THERAPEUTICS INC 11.52 152.57 n/m 0.21 n/a
DSCO DISCOVERY LABORATORIES INC 1.66 141.44 n/m 1.26 180.17
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

PSTI Ind Avg S&P 500
n/m 79.45 19.39

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs